Bariatric surgery for metabolic disorders

British Journal of Surgery

Volumn 95, Issue 11, 2008, Pages 1313-1314

  Greve, J W M ^a   Rubino, F ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL HORMONE; HEMOGLOBIN A1C;

BARIATRIC SURGERY; CALORIC RESTRICTION; DIABETES MELLITUS; DIET; GASTROINTESTINAL SURGERY; GENETIC PREDISPOSITION; HUMAN; METABOLIC DISORDER; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SHORT SURVEY; SURVIVAL; WEIGHT REDUCTION;

BARIATRIC SURGERY; HUMANS; METABOLIC DISEASES;

EID: 55549143992     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6389     Document Type: Short Survey

References (10)

1. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care 2008; 31(Suppl 2): S290-S296.
2. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
3. Pories WJ, Swason MS, MacDonald KG, Long SB, Morris PG, Brown BM et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-350; discussion 350-352.
4. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741-749.
5. 2: a report of 2 cases. Surg Obes Relat Dis 2007; 3: 195-197.
6. Rodriguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, Tarnoff M et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008; 4: 55-59.
7. van Dielen FM, Buurman WA, Hadfoune M, Nijhuis J, Greve JW. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 2004; 89: 4062-4068.
8. Santoro S, Malzoni CE, Velhote MC, Milleo FQ, Santo MA, Klajner S et al. Digestive Adaptation with Intestinal Reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg 2006; 16: 1371-1379.
9. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD et al. Long-term mortality after gastric bypass surgery. N Engl JMed 2007; 357: 753-761.
10. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752.